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Abstract
Since the discovery of human leukocyte antigens (HLAs), the function of major histocompatibility complex (MHC) gene 
families in a wide range of diseases have been the subject of research for decades. In particular, the associations of autoim-
mune disorders to allelic variants and candidate genes encoding the MHC are well documented. However, despite decades 
of research, the knowledge of MHC associations with human disease susceptibility have been predominantly studied in 
European origin, with limited understanding in different populations and ethnic groups. This is particularly evident in coun-
tries and ethnic populations of the Arabian Peninsula. Human MHC haplotypes, and its association with diseases, of the 
variable ethnic groups of this region are poorly studied. This review compiled published manuscripts that have reported a 
list of autoimmune diseases (insulin-dependent diabetes mellitus, systemic lupus erythematosus, myasthenia gravis, rheu-
matoid arthritis, psoriasis vulgaris, and multiple sclerosis) associated with MHC class I and class II in the populations of 
the Arabian Peninsula, specifically Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, the United Arab Emirates, and Yemen. 
Data available was compared with other three ethnic groups, namely Caucasians, Asians, and Africans. The limited data 
available in the public domain on the association between MHC gene and autoimmune diseases highlight the challenges in 
the Middle Eastern region.
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Introduction
In the 1950s, work described by Jean Dausset, Jon van Rood, 
and Rose Payne laid the foundation for what is now known 
as the human major histocompatibility complex (MHC). 
The MHC region is one of the most gene-dense regions of 
the genome that spans 3.6 megabase contiguous sequence 
(The MHC sequencing consortium 1999) to an expanded 7.6 
megabases (Mungall et al. 2003), on chromosome 6p21.3. 
Members of these MHC gene families are involved in self 
recognition (human leukocyte antigens (HLAs)), inflam-
mation (tumor necrosis factor (TNF)), and components of 
the complement cascade (C4, C2 and complement factor B 
or Bf). Human MHC haplotypes may be compared among 
individuals and populations in the form of single nucleo-
tide polymorphisms (SNPs), insertion-deletions (indel), as 
well as gross large-scale differences involving gene copy 
number differences. An example of these three categories 
of genetic variation is evident in the complement C4 gene, 
located in the central region of the MHC. Despite sharing 
99% sequence homology, the two forms of this gene, C4A 
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and C4B, are defined by 5 important nucleotide differences 
in exon 26, which contribute to isotype-specific motifs (Yu 
1991; Yu et al. 1986). A HERV-K(C4) insertion in intron 
9 of some, but not all, C4 genes gives rise to a long (21 kb 
C4L) and a short (14.6 kb C4S) form (Dangel et al. 1994; 
Yu et al. 1986). The complement C4 genes are segmentally 
duplicated as part of one to four modular RCCX cassettes, 
such that two to eight copies of the C4 gene may be present 
in a diploid genome, where each chromosome 6 consisting 
of one to four copies of a single C4 gene (Fernando et al. 
2010).
HLA gene variants were first associated with human dis-
eases in the late 1960s, with the discovery of the susceptibil-
ity effects of HLA-B in Hodgkin’s lymphoma (Amiel 1967). 
Subsequently, many other associations have been established, 
such as the association between HLA-A2 and acute lympho-
cytic leukemia (Walford et al. 1970), the classical HLA-B27 
association with ankylosing spondylitis (Brewerton et al. 
1973; Schlosstein et al. 1973), among others. Since then, 
associations with other non-HLA-genes have been impli-
cated. For example, the presence of C4 null alleles has been 
associated with systemic lupus erythematosus (SLE) (Chris-
tiansen et al. 1983; Fielder et al. 1983), systemic sclerosis 
(Briggs et al. 1993), and myasthenia gravis (Franciotta et al. 
2001). By comparing conserved extended or ancestral haplo-
types of the MHC, some have argued that this C4 null asso-
ciation accounts for only part of the association, and have 
implicated the possible role of other MHC genes (Christian-
sen et al. 1991). Over time, the MHC has been recognized as 
the region of the genome with arguably the greatest number 
of human disease associations (Trowsdale and Knight 2013). 
Interestingly, the influence of MHC genes is not merely con-
fined to immune conditions, but also includes susceptibility 
to neuropathologies, malignancies, and infectious diseases 
(Howell 2014; Trowsdale 2011). With recent advances in 
high-throughput DNA-based technologies and increased 
knowledge of the complexity and extreme polymorphism 
of the MHC, HLA disease associations have subsequently 
been reported.
Population Definition for this Review: 
the Arabian Peninsula
This review focuses on the populations of a region in the 
Middle East, specifically, the Arabian Peninsula. The land 
mass of the Arabian Peninsula comprises of seven countries: 
Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, the United 
Arab Emirates (UAE), and Yemen. The peninsula is sur-
rounded by the Red and Arabian Seas, as well as the Gulfs 
of Arden, Oman, and Persia. It has land borders with Egypt 
to the west, Jordan to the northwest, and Iraq to the north-
east. These connect the peninsula to Africa and the northern 
Levantine region, which leads to Europe and Asia. The pop-
ulation of the Arabian Peninsula, which is often referred to 
as the population of Arabian Gulf, consists of diverse ethnic 
groups, with influences from neighboring regions. The first 
inhabitants were the Bedouins, a group that dates back to at 
least 1200 BC. This group travelled widely throughout the 
Arabian Peninsula in search of water and grazing pastures, 
and their caravans were used by travelers from surround-
ing regions to traverse through the region. Through trade, 
populations from North and sub-Saharan Africa, the Levant, 
and Southern or Central Asia intermingled with the locals, 
with some remaining within the gulf region. A genetic study 
of the present-day population revealed that genetic variants 
of ethnic groups can be traced to Central Asia (Al-Jenaidi 
et al.), Southern Asia (Baluchistan), and North Africa (Iberia 
and Egypt) (Hajjej et al. 2018; Tay et al. 2020).
A genome-wide association analyses, based on systemati-
cally dispersed SNPs across the genomes of 1000 citizens of 
the UAE, has provided some insight into the admixture that 
has occurred over history in the south eastern corner of this 
gulf region, with genetic influences from the Central, South-
ern, and sub-Saharan Africa (Fig. 1) (Tay et al. 2020). Trade 
and exchange throughout history has been well documented 
between these three regions, and as expected, there are 
contributions from populations from North Africa, Central 

















Fig. 1   Proportions of ancestral genomes that have accumulated in 
the contemporary population of the UAE. Data was obtained from 
the genome wide analysis study of 1000 UAE citizens which provide 
insights into the admixture of the contemporary population. The main 
ancestral contribution can be traced back to South Asia (27%) which 
can be explained by a history of trade and exchange between the 
regions (Tay et al. 2020)
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secondary route from central Africa across the Bab al-Mandab 
Strait has also influenced the composition of the population 
in this region. There has been minimal to no influence from 
the East Asia, Oceania, and the Americas. Although a gener-
alization, it is not unexpected that the unique composition of 
the seven countries of the Arabian Peninsula has arisen from 
the gradual admixture of populations that have inhabited the 
region through interactions with those from neighboring 
areas (Fig. 2).
Motivation for this review
The genetic architecture and disease susceptibility among the 
Arabian Peninsula region, including its MHC, remain poorly 
characterized (Popejoy and Fullerton 2016). The Clinical 
Genome Resource Ancestry and Diversity Working Group con-
tinues to highlight the importance of developing guidance for 
incorporating race, ethnicity, and ancestry data for applications 
in clinical genomics. Nevertheless, there is substantial disparity 
across populations in the amount of information available on 
clinically relevant variants in the Genome Aggregation Database 
(gnomAD) (Popejoy et al. 2018). This highlights the importance 
of implementing programs to increase the diversity of genome 
sequencing and clinical genomics, and reduce uncertainty of 
variant interpretation, especially in those that have been poorly 
characterized.
Scope of this review
In keeping with the inclusion of race, ethnicity, and ancestry, 
this review summarizes the association between HLA class I/
II genes and autoimmune diseases in populations of the Ara-
bian Peninsula, contrasting available data with other major 
ethnic groups, including the Caucasian, Asian, and Afri-
can populations. This review primarily focuses on a list of 
major autoimmune diseases, specifically insulin-dependent 
Fig. 2  Histogram showing the distribution of variants number at chro-
mosome 6 with troughs (low variability) and peaks (high variability) 
(Tay et al. 2020). Data were obtained from a genome wide association 
studies on 1,000 UAE citizens. Unsurprisingly, there is a significant 
peak in the number of variants on the short arm of chromosome 6, 
specifically around the MHC region. The MHC contains gene families 
with variable copy numbers. The size of MHC haplotypes can vary 
according to the gene copy number around the HLA class II and C4/
CYP21 regions. The table shows the different gene copy numbers in 
different MHC ancestral haplotypes (Zhang et al. 1990)
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diabetes mellitus, systemic lupus erythematosus, myasthenia 
gravis, rheumatoid arthritis, psoriasis vulgaris, and multiple 
sclerosis. It is well established that predispositions to auto-
immunity is a result of a certain disease-specific variation 
at HLA and non-HLA genes, in addition to epigenetic and 
environmental elements, which lead to the pathophysiology 
of the disease and its clinical features (Ramos et al. 2015). 
Furthermore, the already limited data on autoimmune dis-
eases presented challenges in finding literature on associa-
tions with non-immune-related diseases.
A comprehensive search was performed on PubMed, 
Medline, ScienceDirect, and Google Scholar publications 
from database inception until April 2020. Search terms 
included a combination of free-text terms or controlled 
vocabulary terms for variations of “Arab(ian)” or countries 
within the region of interest (Bahrain, Kuwait, Oman, Qatar, 
Saudi Arabia, the United Arab Emirates (including UAE) 
and Yemen) and “disease association(s)” and “MHC and/
or HLA”. Studies using different HLA typing methods such 
as serological, cellular and molecular methods were con-




The human MHC is an important region of the human 
genome located on chromosome 6. The boundary of 
the region can be fairly arbitrary and is dependent on 
the genes of interest at the exterminates of the region. In 
1999, the MHC sequencing consortium quoted a figure of 
3.6-megabases (Mb) (The MHC sequencing consortium 
1999) from the HSET loci at the centromeric end to the 
P5-15 pseudogene in the telomeric end. Ten years later, 
a region of approximately 4 Mb was referred to with the 
MHC, containing approximately 0.5% (> 150) of the esti-
mated 32,000 known protein coding genes in the genome 
(Shiina et al. 2009). Depending on the haplotype, it is rea-
sonable to suggest that the MHC spans a 4 megabase stretch 
on the short arm of chromosome 6 and contains genes that 
are involved in numerous immune-related process (Shiina 
et al. 2009), as well as transplantation (Ketheesan et al. 
1999; Nakamura et al. 2019; Tay et al. 1995a, b; Zou and 
Stastny 2009).
The detailed organization of the human MHC published 
in 2009 show a region that is densely packed and highly 
polymorphic, with multigene families (Shiina et al. 2009). 
One example is the HLA class II gene cluster, where each 
haplotype contains one copy of the HLA-DRA gene but the 
number of HLA-DRB genes are variable. Specifically, 9 dif-
ferent HLA-DRB genes have been identified in the HLA 
class II region, some are expressed (HLA-DRB1, HLA-
DRB3, HLA-DRB4, and HLA-DRB5) and others are pseu-
dogenes (Shiina et al. 2009). Not all HLA-DRB genes are 
found on a haplotype. Within the organizational structure 
around the C4/CYP21 region, a module known as RCCX, 
containing sequences of CYP21, TNX, and C4 is duplicated. 
However, a haplotype can contain up to four RCCX modules 
(Fernando et al. 2010; Traherne 2008).
These multigene families are involved in an array of dif-
ferent functions. Some are involved in signaling, whereas 
others are transcription factors of the inflammatory response. 
Other loci in this region encode for proteins involved in anti-
gen processing and presentation during the adaptive immune 
response. Further, the region carries genes that encode for 
components that interact with Natural Killer (NK) cells and 
cytokines, as well as components of the complement cascade 
(Shiina et al. 2009).
Genes of the MHC
Genes across the MHC region encode proteins that are 
important for self-recognition (e.g., HLA), inflammation 
(e.g., TNF) and the complement cascade (e.g., C4, C2, and 
Bf). Many of these genes tend to be highly polymorphic, 
some of which are duplicated and present in multiple copies 
(Dawkins et al. 1999).
The highly polymorphic classical class I genes (HLA-A, 
HLA-B, HLA-C) encode peptide binding receptors on the 
cell surface of all nucleated cells. The class I heterodimeric 
cell surface receptor platform contains two polypeptide 
heavy α chains and a β-2 microglobulin, where a peptide-
binding groove is located between the α1 and α2 domains. 
These receptors are responsible for presenting peptide 
fragments of non-self-antigens to cytotoxic CD8+ T cell 
receptors (TCRs). The activation of the T cells could lead to 
tolerance, if the presented peptides are identified as “self,” 
initiation of cell-mediated immunity in case of “non-self” 
antigens, or to a maladaptive autoimmune response in the 
presented “self” peptide was misidentified.
On the other hand, the non-classical class I genes such as 
HLA-F, HLA-G, and HLA-E are characterized by limited 
levels of polymorphisms and lower cell surface expression 
compared to the classical class I genes (Shiina et al. 2009). 
Interspersed between the classical HLA class I genes are 
loci that encode for the MHC class I chain related (MIC) 
proteins, MICA and MICB (Bahram et al. 1994; Leelayuwat 
et al. 1994). These proteins do not appear to have a role in 
antigen presentation but act as a stress-induced self-antigen 
that is recognized by γδ T cells, natural killer (NK), and 
CD8+ T cells (Ghadially et al. 2017).
The classical HLA class II multigene family (HLA-DR, 
HLA-DQ, and HLA-DP) are expressed on the surface of 
antigen-presenting cells (e.g., dendritic cells, macrophages, 
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and B cells), involved in presenting peptides to CD4+ T 
cells (Wieczorek et al. 2017). The HLA class II molecules 
include two polypeptide chains, an α and a β chain (Alfonso 
and Karlsson 2000). There are a number of non-classical 
HLA class II loci, which include HLA-DM and HLA-DO. 
HLA-DM is involved in peptide loading of class II mol-
ecules in the endosomal/lysosomal system, whereas HLA-
DO acts as a chaperon for antigenic peptides (Alfonso and 
Karlsson 2000).
Flanked by the HLA class I and HLA class II regions, 
the central MHC also carries a number of multigene fami-
lies including complement factor genes (C2, C4, and CFB), 
cytokine genes (TNF, LTA and LTB) (Shiina et al. 2009), 
and other genes that are not linked to the immune function 
or inflammation. Many of these genes are duplicated and 
polymorphic (Zhang et al. 1990). The TNF is a multifunc-
tional cytokine, secreted by macrophages and T lymphocytes, 
involved in systematic inflammation. It regulates immune 
cells and protects against tumors. The three complement 
genes (C2, C4, and Bf) in the central portion of the MHC 
encode for proteins involved in the early stages of the com-
plement cascade. As mentioned previously, the actual num-
ber of C4 genes can vary from one to four per haplotype or 
two to eight per diploid genome (Bánlaki et al. 2012; Castley 
and Martinez 2012; Fernando et al. 2008) and it is depend-
ent on the ancestral haplotype (AH) (Zhang et al. 1990). In 
this regard, Zhang et al. (1990) has suggested that relative 
deficiencies of the products of the central MHC genes could 
impact the susceptibility to autoimmune diseases (Zhang 
et al. 1990).
The extensive degree of polymorphism of the MHC genes 
found in humans at the population level is thought to con-
tribute to the success of displaying a broad range of non-
self peptides to the T cell antigen receptor. These variants 
are partly caused by point mutations or gene conversion. 
Variation in HLA genes that produce amino acid changes, 
including those in the peptide-binding groove of the MHC 
molecules, can alter the binding preferences, leading to a 
different peptide-binding repertoire (Dendrou et al. 2018). 
If a change in the HLA molecule provides fitness advantage 
to its host, it will be maintained in the population. Hence, it 
is not surprising that many HLA genes are associated with 
hundreds of diseases, owing to their polymorphic nature 
and role in immune response initiation (van Deutekom and 
Keşmir 2015).
Interestingly, an HLA molecule could increase the like-
lihood of developing a particular disease, while a closely 
related HLA molecule cannot. For instance, HLA-B*27:05 
has been found to cause ankylosing spondylitis, while HLA-
B*27:09 does not have an effect in the disease predisposition 
(Fiorillo et al. 1998). Even though the difference between both 
alleles is minimal, and mainly at the peptide-binding groove, 
it produces an entirely different outcome (van Deutekom and 
Keşmir 2015). HLA-B is known to have the highest number of 
alleles, but HLA-DR/DQ subregion has been associated with 
the highest number of diseases (Kishore and Petrek 2018).
The reporting and naming of HLA alleles and haplo-
types in this review follows the HLA nomenclature sys-
tem described by Marsh (Marsh et al. 2010). The asterisk 
“*” sign indicates that the typing has been performed by a 
molecular method. The digits before the first colon (field 
1) define the type or the allele group. The next set of digits 
(field 2) denotes the subtype, and the third set of digits is 
used to show synonymous variants. Many studies reported 
in this review describe HLA allelic associations to 2-digit 
(first field) or 4-digit (second field) resolution.
HLA allele diversity and MHC haplotypes
According to the international HLA nomenclature commit-
tee, there were 19,031 and 7183 HLA class I and class II 
alleles, respectively, in December 2019. The most frequent 
haplotypes observed were the AH 8.1 haplotype (HLA-
A1-B8-DR3) in Caucasians; the HLA-A*33:03-B*58:01-
DRB1*03:01 combination in Asians, and the HLA-A*30:01-
B*42:01-DRB1*03:02 haplotype in Africans (Gourraud 
et al. 2014). To date, no large-scale study has characterized 
ancestral haplotypes in the ethnic populations of Arabs. 
Based on recent studies of HLA frequencies in the popula-
tion of the UAE, the most frequent HLA-A/HLA-B combi-
nations are HLA-A*02-B*50, HLA-A*02-B*51, HLA-A*26-
B*08, HLA-A*11-B*40, and HLA-A*03-B*50 (Kulski 
et al. 2019). Only two haplotypes from the list of the most 
frequent haplotypes observed in Caucasians, Asians, and 
Africans from the 1000-genome project were observed in 
the top 10 HLA-A-B haplotypes in UAE. In Saudi Arabia, 
HLA-A*02, HLA-B*50, and HLA-B*51 were the most fre-
quent HLA alleles described in the population; whereas in 
neighboring Oman, HLA-A*02, HLA-B*08, and HLA-B*50 
were the most frequent alleles (Hajeer et al. 2009).
Disease associations and the Arabian MHC
Insulin‑dependent diabetes mellitus
Insulin-dependent diabetes mellitus (IDDM), also known 
as type 1 diabetes (T1D), is an autoimmune disease where 
pancreatic islet β cells are destroyed by the immune system, 
resulting in low production of insulin and insulin deficiency. 
Consequently, the control of blood sugar level is disrupted, 
leading to complications that causes serious health issues 
and shortened life expectancy (Polychronakos and Li 2011).
IDDM can affect individuals at any age, but usually devel-
ops at a young age making it a common childhood disease. 
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The incidence of the IDDM among children and adoles-
cents in Saudi Arabia, Algeria, and Morocco rank in top 10 
countries worldwide. The Middle East and North African 
(MENA) region ranks third region in terms of number of 
children and adolescents with IDDM (Nam Han et al. 2017). 
Epidemiological studies in Arab countries show that there 
are between 31.4 and 37.1 new cases per 100,000 population 
(Al-Herbish et al. 2008).
Genome-wide association studies (GWAS) have high-
lighted the complexity of IDDM and have implicated the 
involvement of numerous genes in the development of the 
disease (Noble and Valdes 2011). The insulin (INS), ino-
sitol 1-, 4-, 5-trisphosphate receptor type 3 (ITPR3), cyto-
toxic T-lymphocyte-associated protein 4 (CTLA4), protein 
tyrosine phosphatase, non-receptor type 22 (PTPN22), and 
interleukin 2 receptor alpha (IL2RA) genes are non-HLA 
risk loci that have been confirmed (Steck and Rewers 2011).
The HLA genes represent almost half of the genes found 
to be associated with IDDM. The association of the dis-
ease with HLA class II (HLA-DR, HLA-DQ, and HLA-DP) 
have been found to be linked to the geographic location or 
racial background of individuals (Table 1) (Ikegami et al. 
2006). Alleles that have a strong predisposition to the dis-
ease include HLA-DPB1*04:02, HLA-DPB1*03:01, and 
HLA-DPB1*02:02 (Steck and Rewers 2011). The strong 
linkage disequilibrium between the genes within the MHC 
region makes it difficult to evaluate the direct effect of each 
gene separately. Interestingly, studies on Caucasian families 
showed that a number of HLA class I alleles that contributes 
to the onset of IDDM are also associated with type 2 diabe-
tes (T2D) (Jahromi and Al-Ozairi 2019).
The increasing incidence of IDDM among the popula-
tions of the Arabian Peninsula is thought to be due unhealthy 
lifestyle choices, changes in breastfeeding practices, higher 
hygiene standards, and factors that contribute to vitamin D 
deficiency. Moreover, the high rates of endogamous and con-
sanguineous marriages are also believed to have contributed 
to the higher prevalence of the IDDM and other autoimmune 
diseases (Jahromi and Al-Ozairi 2019).
A study in Saudi Arabia that was conducted on IDDM 
patients revealed a significant correlation between the disease 
and the haplotypes HLA-DRB1*04-DQB1*02:01/02:02. The 
same haplotype association, known as HLA-DR4, was also 
found in Caucasian (Noble and Valdes 2011) and Japanese 
patients (Ikegami et al. 2007). Further, HLA-DPB1*04:01 
was found to be significantly protective in the Saudi Arabian 
population (Al-Hussein et al. 2003).
Studies on the population of Bahrain reported a high 
frequency (70.1%) of haplotypes HLA-DRB1*03:01:01-
DQB1*02:01 and HLA-DRB1*03:01:01-DQB1*03:02 
in IDDM patients (Al-Jenaidi et  al. 2005). The HLA-
DRB1*03:01:01-DQB1*02:01 haplotype (also known as 
HLA-DR3) was also found to have a great susceptibility 
to the disease in Caucasians (Noble and Valdes 2011). 
In contrast, the MHC haplotypes HLA-DRB1*10:01:01-
DQB1*05:01:01, HLA-DRB1*11:01:01-DQB1*03:01:01, 
as well as HLA-DRB1*11:01:01-DQB1*05:01:01 were 
found to be protective in the patients from Bahrain (Table 1) 
(Al-Harbi et al. 2004; Al-Jenaidi et al. 2005).
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a chronic multisys-
tem autoimmune disease that exhibits variable phenotypes 
and severity depending on ethnicity (Adwan 2018). Women 
are predominantly affected (Feldman et al. 2013). Clinical 
features include hematological abnormalities, skin, joint 
diseases, renal disease, and neuropsychiatric complica-
tions (Feldman et al. 2013). Although clinical expression 
studies of SLE in Arabian populations are limited, similar 
phenotypic features and disease factors have generally been 
observed when compared to other populations (Adwan 
2018).
The prevalence of SLE among populations of the Arabian 
Gulf region has been shown to be higher than most other 
ethnicities. Specifically, a recent epidemiological study of 
the population of the UAE revealed an age standardized rate 
of 103 per 100,000 population, which is higher than most 
Caucasian populations (Al Dhanhani et al. 2017).
SLE is a multifactorial disease where genetics, hormo-
nal, and environmental factors are involved (Hachicha et al. 
2018). GWAS studies have highlighted over 80 loci with 
variants that contribute in a cumulative way (Morris et al. 
2012; Yeoh et al. 2018) The exact weight of each genetic 
factor has yet to be determined, but genes of the MHC region 
seem to be heavily involved. HLA class II genes, particu-
larly HLA-DRB1, HLA-DQB1, and HLA-DQA1, have been 
reported as the strongest risk factors, and some alleles have 
been associated with particular clinical phenotypes (Graham 
et al. 2007; Wadi et al. 2014).
Some of the alleles are not directly linked to the SLE 
disease but associated to clinical phenotypes of SLE. For 
example, HLA-DQB1*03 seems to be related with skin man-
ifestations, HLA-DRB1*15 with nephritis, DRB1*10 with 
hematological manifestations, and HLA-DRB1*11 with neu-
rological manifestations (Ke et al. 2018; Wadi et al. 2014).
A worldwide recurrent association has been observed for 
MHC class II alleles HLA-DRB1*03:01, HLA-DRB1*15:01, 
and HLA-DQB1*06:01 (Table 2) (Al-Motwee et al. 2013; 
Fernando et al. 2008). Additionally, a protective effect has 
been reported for HLA-DRB1*14:01 (Graham et al. 2007).
Other MHC genes have also been associated to SLE, 
including genes of the complement cascade (C4A and C4B) 
and TNF. However, LD between these genes and some HLA 
haplotypes make the interpretation of their role in SLE dif-
ficult (Fernando et al. 2008).
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HLA-DRB1*15-DQB1*06 has been confirmed as a risk 
haplotype in Saudi Arabian SLE patients (Table 2). How-
ever, the HLA-DQB1*06 allele frequency (40%) was higher 
than that of HLA-DRB1*15 (20%), suggesting that HLA-
DQB1 might represent an independent association with 
the disease. Moreover, the study found that alleles HLA-
DRB1*16 and HLA-DRB1*04 are protective against the dis-
ease (Table 2) (Al-Motwee et al. 2013). Other associations 
with SLE have also been found within MHC class I, includ-
ing HLA-A*29 and HLA-B*51 (Al-Motwee et al. 2013).
Some contrasting results have been observed depending 
on ethnicity. For example, HLA-DRB3 was found to be a 
protective allele among Saudi Arabians (Wadi et al. 2014), 
contradicting the studies from other populations including 
Malaysians (Chai et al. 2012) and Jamaicans (Smikle et al. 
2002).
Myasthenia gravis
Myasthenia gravis (MG) is a rare, chronic autoimmune 
neuromuscular disease that causes weakness in the skeletal 
muscles. The disease is a result of defects in the transmis-
sion of nerve impulses to muscles due to autoantibodies that 
target molecules at the neuromuscular junction. This causes 
impairment for the neuromuscular transmission in 80% of 
the patients (Avidan et al. 2014). The autoantibodies can act 
opposing to the acetylcholine receptor (AChR), the muscle-
specific kinase (MuSK), or the lipoprotein-related protein 4 
(LRP4). Moreover, the disease can be categorized based on 
the age of onset, thymic abnormalities, ocular involvement 
and type of autoantibodies (Avidan et al. 2014).
The disease can be further classified into early-onset 
MG (EOMG), where patients are less than 50 years old, 
and late-onset MG (LOMG), where patients are more 
than 50 years old. Both EOMG and LOMG have different 
HLA allele(s) associations and disease characteristics. 
For example, EOMG is more common in females and 
LOMG in males (Feng et al. 2019).
The prevalence of MG among European societies has 
been estimated to be around 1 to 5000 (Berrih-Aknin 2014). 
On the other hand, there has been no data available on the 
prevalence of the disease in the population of the Arabian 
Peninsula to date.
The relatively low prevalence of the disease has made 
it difficult for GWAS efforts to cover all probable herita-
bility factors and confirm the specific genetic susceptibil-
ity factor(s). In addition, the LD between the MHC genes, 
including HLA, has also made it difficult to predict the exact 
susceptibility gene.
Other non-HLA genes have been shown to be linked 
to EOMC, including interleukin-10 (IL-10) and cellular 
tyrosine phosphatase 22 (PTPN22) on chromosome 1, cyto-
toxic T cell late antigen 4 (CTLA4) and muscle nicotinic 
acetylcholine receptor α-subunit (CHRNA-1) on chromo-
some 2, TNF-α on chromosome 6, and TNFAIP3-interacting 
protein 1 (TNIP1) on chromosome 5 (Avidan et al. 2014).
In a study by Hajeer et al. (2009) involving patients from 
Saudi Arabia, the haplotype comprising of HLA-B*08 and 
HLA-DRB1*03 was found to be frequent in MG patients. 
Further, HLA-B*08 showed the strongest susceptibil-
ity effect and was linked to young age at onset, and with 
the female gender. Similarly, a recent study performed on 
Swedish patients with AH8.1 showed that HLA-B*08:01 is 
the unique risk factor that marked EOMG (Table 3) (Varade 
et al. 2018).
Interestingly, HLA-B*51 was found to be another risk 
allele in the population of Saudi Arabia, with an allele fre-
quency of 19.3% in the general population (Hajjej et al. 
2018). Another observation was the protective effect of 
HLA-B*50, a common allele in Saudi Arabians, but rarely 
found in other ethnicities (Hajeer et al. 2009).
Rheumatoid arthritis
Rheumatoid arthritis (RA) is an autoimmune disease that 
affects the joints. This long-term disease results in swol-
len and painful joints, most commonly the wrist and the 
hands (McInnes and Schett 2017). The annual incidence of 
RA worldwide is around 3 cases per 10,000 (Saxena et al. 
2017). However, the prevalence of RA in populations of the 
Arabian Peninsula remains uncertain.
Genetic factors, when combined with environmental 
events, can define the pathogenesis of the disease. Multiple 
pathways, including environmental factors (e.g., smoking, 
obesity, and vitamin D) and mucosal microbiome, seem to 
be involved, resulting in the same clinical phenotype. Low 
concordance has been observed between twins, suggesting 
a greater contribution from environmental factors (Firestein 
and McInnes 2017).
Despite more than 100 non-MHC candidates identified, 
genes within the MHC have long been regarded as the major 
genetic risk factor of the disease (Kunz and Ibrahim 2011). 
The individual contributions of non-MHC genes seem to be 
low, but when combined with others, have been suggested 
to increase the risk by interaction (Kurkó et al. 2013; Okada 
et al. 2014). Among these gene variants, PTPN22 (1p13.2), 
PAD14 (1p36.13), and CDK6 (7q21.2) are known to play 
an important role in increasing the risk of the disease (Snir 
et al. 2014).
Gene(s) within the MHC class II region are considered 
to be the main genetic contributor, accounting for more 
than 40% of the genetic risk (Firestein and McInnes 2017). 
The significant genetic risk of RA has been primarily 
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by Gregersen et al. (1987). SE refers to an amino acid 
sequence motif with residues 67 to 74 overrepresented by 
a number of HLA-DRB1 alleles in RA patients. The SE is 
thought to act as a “signal transduction ligand that interacts 
with an evolutionarily-conserved receptors” (de Almeida 
et al. 2011). Their shared amino acid sequences (QKRAA, 
QRRAA, and RRRAA) are located at positions 70 to 74 of 
the third hypervariable region of the HLA-DRB1 antigen-
binding groove (Madeleine et al. 2010). The amino acid 
motif with the strongest association is QKRAA, encoded by 
HLA-DRB1*04:01, followed by QRRAA encoded by HLA-
DRB1*04:04, HLA-DRB1*01:01 and HLA-DRB1*04:05. 
Finally, the rarest of the 3 SE motifs, RRRAA, is encoded 
by DRB1*10:01 (de Almeida et al. 2011). It has been found 
that more than 90% of RA patients express at least one 
of these SE alleles (Firestein and McInnes 2017). Other 
alleles that exhibit risk to RA include HLA-DRB1*01:02, 
HLA-DRB1*04:08, HLA-DRB1*04:10, HLA-DRB1*10:01 
(Table 4). These alleles share one of the three SE homolo-
gous amino acid sequence variants that are associated with 
increased severity of RA in Caucasians (Madeleine et al. 
2010).
The role of these SEs is not fully understood but recent 
studies have highlighted an increase of efficiency in peptide 
presentation to T cells for altered citrullinated peptides. 
This results in production of interleukin 17 (IL-17), inter-
feron gamma (IFN-γ), and anti-citrullinated peptide anti-
bodies (ACPA), which are seen in 80 to 90% of the patients 
(Firestein and McInnes 2017).
Furthermore, a list of diseases has also been associated 
to the same SEs including polymyalgia rheumatica, giant 
cell arteries, IDDM, SLE, autoimmune hepatitis, chronic 
lymphoid leukemia, and psoriatic arthritis (de Almeida 
et al. 2011).
A study conducted on RA patients in Saudi Arabia 
using a polymerase chain reaction sequence specific prim-
ers (PCR-SSP) method revealed that the strongest risk 
allele is HLA-DRB1*04 followed by HLA-DRB1*08 and 
HLA-DRB1*10, when compared with healthy controls 
(Al-Swailem et al. 2006). Further subtyping of the HLA-
DRB1*04 locus of the patients has showed strong associa-
tion with 11 subtypes, specifically HLA-DRB1*04:01, HLA-
DRB1*04:02, HLA-DRB1*04:03:01, HLA-DRB1*04:03:02, 
HLA-DRB1*04:04, HLA-DRB1*04:05, HLA-DRB1*04:06, 
HLA-DRB1*04:08, HLA-DRB1*04:10, HLA-DRB1*04:14, 
and HLA-DRB1*04:24.
Further comparison has indicated a significantly positive 
association of the disease to HLA-DRB1*04:05, which is 
one of the shared epitopes. A negative association of HLA-
DRB1*04:03 with RA has also been reported (Table 4) (Al-
Swailem et al. 2006). Surprisingly, a significant protective 
effect of RA has been observed in HLA-DRB1*06 indicating 
that HLA-DRB1 could have both negative and postive cor-
relation with the disease (Al-Swailem et al. 2006).
A study on 69 children in Kuwait with juvenile Rheumatoid 
arthritis using PCR-SSP showed a high incidence of HLA-DR3 
in patients, when compared to the control group. The study 
revealed that this was due to the significant contribution of 
HLA-DRB1*03:07 and HLA-DRB1*03:08 alleles (Table 4) 
with no other HLA-DR alleles found in this study (Alsaeid 
et al. 2002).
A recent pan-Arabian RA genetics GWAS study of 
patients from the UAE, Saudi Arabia, Qatar, Lebanon, and 
Jordan reported replication of associated HLA alleles to 
those of European ancestry. Imputation of the HLA alleles 
and the HLA amino acid polymorphisims have confirmed 
the significant effect of HLA-DRB1 amino acid position 11 
to RA predisposition in Arabs. Moreover, two novel Arab-
specific loci reached genome-wide significance in associa-
tion analyses of RA (Saxena et al. 2017).
Psoriasis vulgaris
Psoriasis vulgaris (PV) is a common hyper proliferative 
dermatosis that causes the skin to flake particularly around 
joints. It is characterized by abnormal symmetrical epider-
mal proliferation accompanied by an inflammatory response. 
The disease affects around 1% of the world population, but 
its prevalence in Arabian populations has not been accu-
rately defined (Capon 2017). Potential triggers of PV are 
believed to involve a combination of genetic and environ-
mental factors including physical trauma, infections, stress, 
alcohol, smoking, and obesity (Capon 2017).
Genetic studies have revealed more than 30 SNPs associ-
ated with PV, affecting both the skin and the immune system. 
Nevertheless, only two SNPs have been found to cause the 
disease independently. GWAS have revealed that the MHC 
region accounts for the highest association signal observed 
in patients with threshold of P < 5.0 × 10–8 (Ayala-Fon-
tanez et al. 2016). The most significantly associated alleles, 
being HLA-C*06 and HLA-B*57, have been described by 
Schmitt-Egenolf et al. (1993). The alleles appear to mark 
MHC haplotypes with the greatest disease risk. In particu-
lar, the association with HLA-C*06 allele is very strong 
and has been found in more than 60% of psoriasis patients 
(Table 5) (Ayala-Fontanez et al. 2016). Moreover, the ances-
tral haplotype (AH), specifically AH57.1 (HLA-C*06-B*57-
DRB1*07:01-DQA1*02:01-DQB1*03:03), was the first to be 
observed in PV with 26 times higher frequency in patients 
than in controls (Szczerkowska-Dobosz 2005). Further, dif-
ferential expression of the MICA and MICB in the class I 
region of the MHC have been found to be potentially impli-
cated in the etiology of the disease (Tay et al. 2000).
A study in Oman conducted on 55 local PV patients 
showed contradicting disease association results. The 
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HLA-C6 antigen was reported in 27.8% of the patients and 
16% in controls, but showed no significant contribution to 
disease risk (Al-Mamari et al. 2009). Moreover, HLA-B57 
was reduced in both groups and no increase was observed for 
HLA-DR7 in patients. A novel association, with HLA-B52, 
was reported as a potential risk allele for PV in the Ara-
bian population of Oman. The study also reported a nega-
tive association between a number of HLA alleles and the 
disease including HLA-A68, HLA-DR13, HLA-DR52, and 
HLA-DQ2 (Table 5) (Al-Mamari et al. 2009). Although the 
result of this study suggests that there are selective racial 
and environmental factors contributing to the etiology of 
the disease the sample size is too small and larger regional 
efforts will be required.
Multiple sclerosis
Multiple sclerosis (MS) is demyelinating disease of the 
central nervous system where the immune system attacks 
the myelin sheath of the neurons. This causes disruptions 
in sensory, motor, autonomic and neurocognitive functions. 
The incidence of the disease is approximately tenfold higher 
risk in the Caucasian population, when compared to other 
populations from around the world, with a prevalence of 
approximately 108 per 100,000. Women and young adults 
with ancestry from Northern and Central Europe were found 
to be particularly at a higher risk of developing MS (Moham-
med 2016). There has been an increase in the number of MS 
diagnosed in the Arabian Gulf region, rising from 31 to 55 
MS cases per 100,000 individuals in a 2016 report (Moham-
med 2016).
Around 50 genome-wide screens have been performed 
to investigate the role of MHC and non-MHC genes in the 
risk to MS. However, as suggested by Schmidt et al. (2007), 
MS is not a homogenous disease with a single-locus model, 
but a collection of diseases with different genetic etiologies 
(Schmidt et al. 2007).
Possible non-MHC genetic risk of the disease includes 
the myelin oligonucleotide glycoprotein (MOG), which lies 
in the MHC class I region (Wadi et al. 2014). It represents 
a component of the myelin expressed on the outer surface 
of the sheath that wraps around the neurons and exons. It is 
believed that when disrupted, it could influence the action 
potential electrical conduction that might lead to MS. How-
ever, its function in the progression of the disease has been 
questioned in recent years (Bronge et al. 2019).
Case–control and family-based research have revealed 
that haplotype DRB1*15:01-DQA1*01:02-DQB1*06:02 
is strongly associated to MS in different ethnic groups 
(Schmidt et al. 2007). Interestingly, this haplotype has also 
been linked to other diseases, including narcolepsy and 
SLE (Mohammed 2016). In Saudi Arabian patients, HLA-
DRB1*15:01, HLA-DQB1*06:02, and HLA-DQB1*06:01 
have been shown to confer the highest risk to MS, with 
HLA-DRB1*15:01 showing an increased risk of previous 
relapses. The HLA-DRB1*15:01 allele seems to present the 
largest risk to MS in populations around the world including 
Caucasians (Patsopoulos et al. 2013), the Chinese (Qiu et al. 
2011), and some populations in the Middle East (Galehdari 
et al. 2018) (Table 6).
On the other hand, the HLA-DQB1*02:03, HLA-
DQB1*05:03, and HLA-DQB1*06:14 alleles were not found 
in the Saudi Arabian MS group (Table 6) (Al Jumah et al. 
2018). Further, the same study showed that patients that car-
ried HLA-DRB1*15:01 and HLA-DQB1*06:02 had lower 
levels of vitamin D in serum when compared to those without 
these alleles (Al Jumah et al. 2018). The vitamin D effect is 
of a particular interest as it has been linked to MS suscep-
tibility and the alteration of MHC class II gene expression 
(Handunnetthi et al. 2010). Specifically, a previous study by 
Ramagopalan et al. (2009) has revealed that the expression 
of HLA-DRB1*15:01 may be controlled by vitamin D. More 
research is required to investigate the interaction between 
HLA allele expression and vitamin D, especially in the popu-
lations of the Arabian Gulf where vitamin D deficiency is 
common (Singh et al. 2019).
A study conducted on MS patients in Bahrain using tis-
sue typing methods by polymerase chain reaction (PCR) 
reported a number of HLA associations, suggesting that 
there might be population-specific genetic factors that 
contribute to susceptibility or protection to MS among the 
populations of the Arabian Gulf. The study did not find any 
significance between HLA-DRB1*15:01 allele and patients 
from Bahrain. A number of HLA class I alleles, specifi-
cally HLA-A19, HLA-A2, HLA-A9, HLA-B35, HLA-B40, 
and HLA-B5, where found elevated in MS patients, while 
HLA-A10 showed a protective effect against the disease. 
Some HLA class II antigens, specifically HLA-DR3, HLA-
DR4, and HLA-DR5, were also found to be higher in patients 
(Table 6) (Al-Nashmi et al. 2018). The associations found in 
the study differed to those reported in Caucasians but similar 
to a study on patients in another gulf country, Kuwait (Al-
Shammri et al. 2004).
Other MHC associated diseases with no data 
available in the Arabian Gulf population
Although there are a number of studies demonstrating the 
involvement of MHC genes in susceptibility to autoimmune 
diseases for the Arabian Gulf populations, a clear picture is 
still far from available. There is progress in elucidating the 
genetic elements of major autoimmune diseases, but many 
have not been adequately studied in the populations of the 
Arabian Peninsula region. These include the deficiency in 
information on Hoshimoto thyroiditis, Addison’s disease, 
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celiac disease, polymyalgia rheumaticia, autoimmune hepa-
titis, polyglandulat, and Behçet’s disease (Table 7). Some of 
diseases, such as celiac disease, are very common among the 
populations of the Arabian Peninsula (Saeed et al. 2017). 
However, due to the lack of organized national and regional 
epidemiological studies, the exact levels of prevalence of 
many of these diseases remain unknown. More effort is 
needed to improve our understanding of the MHC region 
and its association with autoimmune diseases in the popula-
tions of the Arabian Peninsula, and the surrounding Middle 
East region.
Conclusion
Published manuscripts on Arabian HLA-disease associations 
show inconsistent results from one population to another 
(e.g., IDDM, RA, and MS). The significance of studies 
involving Arabian populations have been compromised by 
methodological heterogeneity, due to low sample size and 
participant selection, effecting the robustness of the results. 
The studies have also tended not to adjust for co-morbidities, 
and did not provide information on whether the participants 
were diagnosed with any other autoimmune diseases, leading 
to possible statistical heterogeneity and confounding results. 
Hence, the sample size and study design of the included 
manuscripts, limited meaningful interpretation of the data.
It is evident that HLA allele and MHC haplotype frequen-
cies vary according to ethnicity and geographic origin. Vari-
ation among closely related ethnic groups can be classified 
by haplotype distribution, LD analysis and different allele 
frequencies (Hajjej et al. 2018). Manuscripts on the MHC 
region of the Arabian Peninsula have presented allele or 
haplotype associations. Yet, the majority of the reports have 
been based on serological methods and low resolution DNA-
based HLA typing. Hence, the accuracy of HLA genotyping 
is particularly important to confirm disease associations.
Challenges faced by HLA-disease association studies 
include incomplete penetrance, interactions between genes, 
epigenetic factors, and environmental influences which all 
contribute to the clinical manifestation and phenotype sever-
ity of the disease, making it difficult to reach a conclusive 
genetic association (Dendrou et al. 2018). Disease associa-
tion studies are negatively impacted by the rising number of 
HLA alleles and the ambiguity from the use of traditional 
methods (e.g., SSOP), compared to sequencing methods. 
To overcome these limitations, Next Generation Sequenc-
ing (NGS) methods may be used to provide consistent levels 
of resolution of HLA typing (Brown et al. 2016), and col-
laborative workshop activities focused on Middle Eastern 
populations may encourage further research in the region.
As suggested, typing based on NGS should provide the 
appropriate level of analytical specificity and sensitivity, 
reduce ambiguity, and provide more accurate allelic infor-
mation for disease association studies (Profaizer et al. 2020). 
Publications describing DNA-based HLA typing are increas-
ing, and with the decreasing cost of next generation sequenc-
ing technology (Klasberg et al. 2019), there is no doubt that 
the pool of data and our understanding of MHC disease 
associations will improve. NGS technology has proven its 
ability in identifying novel HLA alleles undetected by the 
clinical Sanger sequencing-based typing (SBT) (Brown et al. 
2016). Particularly, NGS has successfully utilized to detect 
33 novel alleles in Saudi Arabian potential bone marrow 
donors (Bishara et al. 2020), despite allelic definitions of 
HLA in public databases remain limited.
Table 7  Autoimmune diseases 
and HLA association that 
have not been studied in the 
population of the Arabian 
Peninsula. Alleles or haplotypes 
in brackets are protective
Disease Ethnicity Alleles/haplotypes Reference
Hashimoto’s thyroiditis Arabian No data or research
Others HLA-DR4, HLA-DR3, HLA-DR7 (Gough and Simmonds 2007)
Addison’s disease Arabian No data or research
Others HLA-DR3 (Gough and Simmonds 2007)
Celiac disease Arabian No data or research
Others HLA-DQ2, HLA-DQ8 (Gough and Simmonds 2007)
Polymyalgia rheumatica Arabian No data or research
Others HLA-DR4 (Cid et al. 1988)




Polyglandular syndrome Arabian No data or research
Others HLA-DRB1*03, HLA-DRB1*04, 
HLA-DQA1*03, HLA-DQB1*02
(Weinstock et al. 2011)
Behçet’s disease Arabian No data or research
Others [ HLA-A*03], HLA-B*51 (Wallace 2014)
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It has been well established that HLA genes are in strong 
long-range linkage disequilibrium leading to the existence of 
“conserved extended” (CEH) (Yunis et al. 2003) or “ances-
tral” (AH) (Degli-Esposti et al. 1992) haplotypes. These 
MHC haplotypes are not transmitted randomly through 
generations. Rather, there is transmission of specific MHC 
genomic subregions comprising hundreds of kilobases in 
length (Dawkins et al. 1999). Therefore, the susceptibility 
for diseases should be looked at from the perspective of 
MHC ancestral haplotypes and their recombinants (Dawk-
ins and Lloyd 2019).
The MHC ancestral haplotype and the genetic architec-
ture of the Arabian Peninsula population is not well docu-
mented, if at all. Studying Arabian MHC ancestral haplo-
types, is important to provide a reference for the presence 
and prevalence of HLA haplotypes and alleles in the popula-
tion (Kishore and Petrek 2018). This will augment research 
on HLA-disease susceptibility and improve histocompatibil-
ity matching for hematopoietic stem cells and bone marrow 
(Ameen et al. 2020) for patients of this region.
Construction of MHC ancestral haplotypes in the region 
could be possible through family studies as they improve the 
statistical power of analyses (Jahromi and Al-Ozairi 2019), 
and provide the opportunity to dissect the specific MHC 
region of interest (Dawkins et al. 1999). Finally, this review 
highlights the need for greater effort into characterizing the 
MHC region and associated diseases for the Arabian popula-
tion. This is needed to assist in early diagnosis, future pre-
vention and treatment of the disease, in addition to optimiz-
ing the matching of bone marrow donor and recipient pairs, 
as well as the organ distribution for transplant purposes in 
the region.
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